Market Overview

Benzinga's Top Pre-Market Gainers

Related MNKD
Benzinga's Top Initiations
Jefferies Initiates MannKind At Buy, Shares Rise
MannKind: FDA Delays Afrezza Decision by Three Months (Fox Business)
Related BRCD
Pacific Crest Securities Sees Data Center And International Drive Upside For Brocade Communications Systems
Wunderlich Securities Sees Stronger-Than-Expected F3Q14 Results For Brocade Communications Systems
Good Time to Buy Brocade Communications? (Fox Business)

MannKind (NASDAQ: MNKD) moved up 17.35% to $8.05 in the pre-market session after the company reported positive clinical data for AFREZZA.

Brocade Communications (NASDAQ: BRCD) soared 14.49% to $7.90 in the pre-market trading after the company reported better-than-expected fiscal third-quarter results.

Osiris Therapeutics (NASDAQ: OSIR) surged 9% to $27.73 in the pre-market session on clinical study results.

GenMark Diagnostics (NASDAQ: GNMK) shares gained 4.65% to $10.35 in the pre-market session after the company priced 7.6 million shares of common stock at $9.84.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (BRCD + GNMK)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters